3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector
RxNorm concept 1858995, clinical drug (scd). Prescribable name: insulin glargine 100 UNT/ML / lixisenatide 33 MCG/ML in 3 ML Pen Injector.
- RxCUI
- 1858995
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1858995 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
insulin glargine 100 UNT/ML / lixisenatide 33 MCG/ML per 3 ML Pen Injector
Related concepts
- insulin glargine 100 UNT/ML (SCDC, consists of)
- lixisenatide 0.033 MG/ML (SCDC, consists of)
- Pen Injector (DF, has dose form)
- 3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector [Soliqua] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1858995 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1858995 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1858995. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.